Eupraxia Pharmaceuticals Inc. Archives - Vista Partners LLC

From Under the Radar to Over the Moon? Raymond James Puts a Strong‑Buy Spotlight on Eupraxia – $EPRX $IBB $SNY $XBI )

by John F. Heerdink, Jr. 2 days ago 165Views 0Likes

Eupraxia Pharmaceuticals (NASDAQ: EPRX) just earned a fresh vote of confidence from Raymond James, which is doubling down on its bullish thesis and arguing that the small-cap biotech now offers one of the most attractive risk/reward setups heading into 2026. The Raymond…

Eupraxia Steps Into the Spotlight: AAAAI 2026 Puts EoE Back on the Growth Map -( $EPRX $SNY $REGN $IBB $XBI )

by John F. Heerdink, Jr. March 2, 2026 298Views 0Likes

In a conference season dominated by mega-cap immunology franchises, Eupraxia Pharmaceuticals (NASDAQ: EPRX) quietly walked into AAAAI 2026 and walked out looking a lot less “micro‑cap” and a lot more “mispriced asset.” For investors willing to do more than skim the abstracts,…

Eupraxia’s Latest Raise: A Diffusphere-Fueled War Chest Aims at GI Disease -( $EPRX $IBB $XBI $SNY)

by John F. Heerdink, Jr. February 21, 2026 183Views 0Likes

In a market that has grown wary of “story stocks,” Eupraxia Pharmaceuticals (NASDAQ: EPRX) just delivered something refreshingly old-fashioned: a fully closed, upsized equity offering that actually funds a clinical plan rather than a marketing slogan. The clinical‑stage biotech, which trades on…

U.S. Stocks Propel Forward On Monday – February 9, 2026 -( $AVGO $DV $FLYX $META $NOK $NVDA $OKLO $OPEN $ORCL $PLTR $RIO $TSLA $TSM Rise!)

by John F. Heerdink, Jr. February 10, 2026 5428Views 0Likes

US stocks extended last week’s relief rally on Monday, with megacap tech doing most of the heavy lifting while value names tried to remember what outperformance felt like. Investors spent the session toggling between AI euphoria, tariff anxiety and a yield curve…

Eupraxia Pharmaceuticals: Injecting New Life Into EoE — One Microsphere at a Time -( $EPRX $SNY $XBI )

by John F. Heerdink, Jr. February 9, 2026 320Views 0Likes

Eupraxia Pharmaceuticals (NASDAQ: EPRX) may still wear the “clinical-stage” name tag, but its stock has been behaving like it already found a seat at the grown‑ups’ table on Wall Street. Over the past year, shares have climbed roughly 160%, far outpacing the…

Dow Breaks 50,000 as Wall Street Limps, Then Leaps Into the Weekend – February 6, 2026 -( $DIA $EPRX $FLYX $LLY $MCD $MANE $MODD $NOK $RIO Rise!)

by John F. Heerdink, Jr. February 6, 2026 5370Views 0Likes

Wall Street closed the week ending Feb. 6, 2026 looking a bit like a trader after a rough options expiry: bruised, but suddenly energetic once the bell rang on Friday. The Dow finally cracked the 50,000 mark in a more-than-1,000‑point sprint, while…

Stock Market Trades Like a Slightly Over-Caffeinated & Negative Economist – February 5, 2026 -( $MODD $PAHC $VIX Rise!)

by John F. Heerdink, Jr. February 6, 2026 5263Views 0Likes

US stocks spent Thursday behaving like a slightly over-caffeinated, negative economist: plenty of motion & an overall negative conviction, as investors digested another wave of tech volatility, macro cross-currents, and a busy new-issue calendar heading into Friday’s jobs data. As evidence the…

Gold & Silver Glittered, AI Wobbled, & Eli Lilly Powered Double Digits – February 4, 2026 -( $DV $GLD $GOVX $INTG $LLY $MCD $NOK $RIO $SLV Rise!)

by John F. Heerdink, Jr. February 5, 2026 5242Views 0Likes

In a fitting summary for the day, hard assets glittered, AI narratives wobbled, and Eli Lilly proved that in 2026, the market’s favorite growth story is just as likely to come from the medicine cabinet as from the data center. Broadly on…

Small Caps Move Higher While AI Large Caps Tumble – February 3, 2026 -( $INTC $KMB $MCD $MTWO $NOK $OKLO $OPEN $PLTR $RIO $SOAR $TSLA Rise!)

by John F. Heerdink, Jr. February 4, 2026 5195Views 0Likes

U.S. stocks lost a bit of altitude on Tuesday, as the AI trade paused for breath and investors briefly remembered that prices can, in fact, go down. But that is not all of the story as the small caps on the Russell…

Market Rally Today: AI Giants, Blue Chips, and Small Caps Kick Off February in Style -( $AAPL $FLYX $GOVX $INTC $LLY $MCD $MODD $MU $NOK $RIO $TSM Rise!)

by John F. Heerdink, Jr. February 3, 2026 5109Views 0Likes

U.S. stocks launched February with a flourish, as major indexes shrugged off weekend volatility in commodities and crypto to end Monday sharply higher. S&P 500: Brushing Past Its Nerves The S&P 500 spent the day flirting with record territory, ultimately closing just…

Eupraxia Pharmaceuticals Inc.

Your Guide To Staying Informed In The Markets